Table 3.
—Values for Lung Function and Changes in Dyspnea at Visits 3 and 4
| Variables | Visit 3 | Visit 4 | ICC (95% CI) |
| Gender, No. | |||
| Female | 46 | ||
| Male | 43 | ||
| Age, yr | 67 ± 8 | ||
| Height, cm | 167 ± 9 | ||
| Weight, kg | 79 ± 20 | ||
| FEV1 | |||
| L | 1.26 ± 0.50 | 1.27 ± 0.48 | 0.98 (0.97–0.99) |
| % predicted | 53 ± 18 | 53 ± 17 | 0.95 (0.92–0.97) |
| FVC | |||
| L | 2.80 ± 0.82 | 2.85 ± 0.84 | 0.95 (0.92–0.97) |
| % predicted | 82 ± 17 | 83 ± 16 | 0.85 (0.77–0.91) |
| IC | |||
| L | 1.98 ± 0.58 | 1.98 ± 0.62 | 0.96 (0.94–0.97) |
| % predicted | 76 ± 20 | 76 ± 20 | 0.95 (0.92–0.97) |
| mMRC scale* | −0.04 ± 0.7 | −0.09 ± 0.9 | 0.82 (0.72–0.88) |
| SAC TDI | −0.1 ± 2.5 | −0.1 ± 1.9 | 0.84 (0.76–0.90) |
| UCSD | 0.2 ± 14.3 | −0.1 ± 14.9 | 0.89 (0.84–0.93) |
| SOBQ* |
Values are presented as the mean ± SD, unless otherwise indicated.
*
Differences in dyspnea scores compared with values at visit 1. A negative value for dyspnea scores indicates worse dyspnea.